Concentrations |
12 Months Ended |
|---|---|
Dec. 31, 2021 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations |
Note L - Concentrations Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021 and 2020. Revenue from two licensees constituted an aggregate of 99% of the Company’s revenue for the year ended December 31, 2021. Revenue from one licensee constituted an aggregate of 94% of the Company’s revenue for the year ended December 31, 2020. At December 31, 2021 and December 31, 2020, there were no royalty receivables from licensees. |
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|